ALLE vs BBIO · P/E 21, rev $2.19B vs rev $438.2M
Allegion PLC (ALLE) versus BridgeBio Pharma Inc (BBIO) — a side-by-side from cached financials, not a winner call.
Allegion PLC (ALLE) is a security & protection services company listed on US.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Latest reported ALLE revenue for 2026-06-30 was $2.19B. Net income was $322.7M. ALLE currently screens at market cap $12.71B and trailing P/E 20.7.
Latest reported BBIO revenue for 2026-06-30 was $438.2M. Net income was -$322.4M. BBIO currently screens at market cap $13.24B.
ALLE currently screens at market cap $12.71B and trailing P/E 20.7. BBIO currently screens at market cap $13.24B.
Not investment advice. Open the ALLE and BBIO stock pages for the full models.
Not investment advice.